Streetbeat News

Earnings

CYBN

Cybin announced positive Phase 2 topline results for its investigational drug CYB003, achieving the primary efficacy endpoint with rapid and statistically significant improvements in depression symptoms after a single dose.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:34 pm

FL

Foot Locker, Inc. (NYSE:FL) reported Q3 FY23 sales of $1.99 billion, surpassing estimates of $1.97 billion, with adjusted EPS of $0.30 beating the $0.25 consensus. The company improved its FY23 sales and comparable sales guidance, leading to a 16.1% stock increase. Telsey Advisory Group and Citigroup updated their price targets for Foot Locker following the earnings announcement.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 12:30 pm

SNOW

Snowflake Inc. (NASDAQ:SNOW) reported Q3 financial results exceeding expectations with a 32% year-over-year revenue increase to $734.17 million and earnings of 25 cents per share. The company anticipates Q4 product revenue between $716 million and $721 million, and full-year product revenue of $2.65 billion. Following the announcement, Snowflake's shares rose 8.2% in pre-market trading, and analysts from Piper Sandler, Needham, Morgan Stanley, and JP Morgan raised their price targets while maintaining positive ratings.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 12:21 pm

SNT

Senstar Tech (NASDAQ:SNT) reported a decrease in Q3 earnings to $(0.01) per share from $0.06 YoY, with sales falling 7.91% to $8.97M from $9.74M YoY.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:20 pm

TSLA

Tesla, Inc. (NASDAQ:TSLA) shares are poised for a rebound in premarket trading after a 1%+ drop on Wednesday. The anticipation of the Cybertruck delivery event, scheduled for 3 p.m. ET on Thursday, could drive momentum and potential volatility. While the Tesla community is optimistic, analysts like Gene Munster and Philippe Houchois express caution, citing capacity constraints and timing concerns. Tesla's stock has shown recovery from its October 31 low, and positive reception to the Cybertruck could test resistance levels at $255.7 and $274.5, with support at $233 and $215.

Portfolio Pulse from Shanthi Rexaline

November 30, 2023 | 12:18 pm

CANF

Can Fite Biofarma (AMEX:CANF) reported a 4.08% decrease in sales for the 9-month period, with current sales at $588.00K compared to $613.00K in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:16 pm

GAME

Gamesquare, a company specializing in performance marketing services, has announced a record monthly contract, signaling accelerated customer and sales growth. The company now anticipates that its performance marketing sales will generate over $10 million in annual revenue by 2024.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:10 pm

ACTG

CPBI

HWBK

PEBK

RILY

The article highlights the top 5 oversold financial stocks with an RSI near or below 30, indicating potential undervaluation. B. Riley Financial (RILY) reported a Q3 loss but expects to capitalize on market dislocations. Acacia Research (ACTG) also posted a Q3 loss and is focusing on acquiring oil and gas assets. Central Plains Bancshares (CPBI), Peoples Bancorp of North Carolina (PEBK), and Hawthorn Bancshares (HWBK) all showed declines in their stock prices with low RSI values, suggesting they may be oversold.

Portfolio Pulse from Lisa Levin

November 30, 2023 | 12:08 pm

BIG

Big Lots reported a 13.2% decrease in comparable store sales for Q3, with a net decrease in store count contributing approximately 150 basis points to the sales decline compared to Q3 of 2022.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:05 pm

CHS

Chico's FAS reported a decrease in sales to $505.13M in Q3, down from $518.33M in the same period last year, with adjusted earnings of $0.11 per share.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 12:03 pm